$AZN News Article - Datopotamab deruxtecan demonst
Post# of 47038
(Total Views: 124)
Posted On: 09/22/2023 1:20:50 PM
$AZN News Article - Datopotamab deruxtecan demonstrated statistically significant and clinically meaningful progression-free survival benefit in patients with HR-positive, HER2-low or negative breast cancer in TROPION-Breast01 Phase III trial https://marketwirenews.com/news-releases/dato...06904.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼